Skip to main content
. 2016 Jan 21;35:15. doi: 10.1186/s13046-016-0294-2

Fig. 8.

Fig. 8

Kaplan-Meier analysis of disease-free survival (DFS) and overall survival (OS) in 264 GC patients. a DFS and OS of patients according to HOXA1 expression levels determined by immunohistochemical staining. The survival rate of patients with HOXA1-positive tumors was significantly lower than that of patients with HOXA1-negative tumors (P < 0.001). b DFS and OS were significantly worse in patients with cyclin D1-positive tumors than in patients with cyclin D1-negative tumors (P < 0.001). c DFS and OS were significantly lower in patients with HOXA1- and cyclin D1-positive tumors than in patients with HOXA1- and cyclin D1-negative tumors (P < 0.001)